{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:10:14Z","timestamp":1793092214636,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.vaccine.2008.09.082","type":"journal-article","created":{"date-parts":[[2008,10,19]],"date-time":"2008-10-19T04:09:43Z","timestamp":1224389383000},"page":"6894-6900","source":"Crossref","is-referenced-by-count":176,"title":["Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses"],"prefix":"10.1016","volume":"26","author":[{"given":"Thomas W.","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Daddario-DiCaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Grolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Str\u00f6her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.09.082_bib1","series-title":"Virus taxonomy: VIIIth report of the international committee on taxonomy of viruses","first-page":"645","article-title":"Filoviridae","author":"Feldmann","year":"2004"},{"key":"10.1016\/j.vaccine.2008.09.082_bib2","series-title":"Fields virology","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola viruses","author":"Sanchez","year":"2006"},{"key":"10.1016\/j.vaccine.2008.09.082_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.09.082_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.082_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.082_bib6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine platform protects non-human primates against lethal challenge with either Ebola virus or Marburg virus","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2008.09.082_bib7","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib8","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2008.09.082_bib9","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J Virol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.09.082_bib10","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.082_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00431-07","article-title":"Complete protection of nonhuman primates against multi-strain Ebola and Marburg virus infections","author":"Swenson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.09.082_bib13","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2008.09.082_bib14","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nature01566","article-title":"Catastrophic ape decline in western equatorial Africa","volume":"422","author":"Walsh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.082_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tim.2007.08.001","article-title":"The ecology of Ebola virus","volume":"15","author":"Groseth","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/438575a","article-title":"Fruit bats as reservoirs of Ebola virus","volume":"438","author":"Leroy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.09.082_bib18","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1371\/journal.pone.0000764","article-title":"Marburg virus infection detected in a common African bat","volume":"2","author":"Towner","year":"2007","journal-title":"PLoS ONE"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.09.082_bib19","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1086\/520542","article-title":"Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient","volume":"196","author":"Bausch","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.082_bib20","first-page":"153","article-title":"The influence of the methods of experimental infection with Marburg virus on the course of illness in green monkeys","volume":"3","author":"Bazhutin","year":"1992","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib21","first-page":"227","article-title":"Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus","volume":"76","author":"Johnson","year":"1995","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib22","first-page":"158","article-title":"Certain pathogenetic characteristics of a disease in monkeys in infected with the Marburg virus by an airborne route","volume":"40","author":"Lub MIu","year":"1995","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib23","first-page":"113","article-title":"Experimental Ebola fever in Macaca rhesus","volume":"3","author":"P\u2019yankov","year":"1995","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib24","unstructured":"Centers for Disease Control and Prevention. Category A Agents. Available at: http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp#a (Accessed July 29, 2008)."},{"key":"10.1016\/j.vaccine.2008.09.082_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.278.5.412","article-title":"Biological warfare. A historical perspective","volume":"278","author":"Christopher","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.09.082_bib26","unstructured":"Alibek K. Testimony before the Joint Economic Committee, United States Congress, Wednesday, May 20, 1998. Available at: http:\/\/www.house.gov\/jec\/hearings\/intell\/alibek.htm (Accessed July 29, 2008)."},{"key":"10.1016\/j.vaccine.2008.09.082_bib27","series-title":"Told from the inside by the man who ran it","article-title":"Biohazard: the chilling true story of the largest covert biological weapons program in the world.","author":"Alibek","year":"1999"},{"key":"10.1016\/j.vaccine.2008.09.082_bib28","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2008.09.082_bib29","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1086\/514310","article-title":"Evaluation of immune globulin and recombinant interferon \u03b1-2b for treatment of experimental Ebola virus infections","volume":"179","author":"Jahrling","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.082_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(82)91871-2","article-title":"Marburg-virus disease in Kenya","volume":"1","author":"Smith","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.09.082_bib31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1086\/382281","article-title":"Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses","volume":"189","author":"Reed","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.082_bib32","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.09.082_bib33","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","article-title":"Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection","volume":"163","author":"Geisbert","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0021-9975(92)90043-T","article-title":"Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States","volume":"106","author":"Geisbert","year":"1992","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib35","first-page":"140","article-title":"Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure","volume":"120","author":"Jaax","year":"1996","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.vaccine.2008.09.082_bib36","series-title":"Ebola virus haemorrhagic fever","first-page":"103","article-title":"The epidemiology of Ebola haemorrhagic fever in Zaire 1976","author":"Breman","year":"1978"},{"key":"10.1016\/j.vaccine.2008.09.082_bib37","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.ppat.0030009","article-title":"Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys","volume":"3","author":"Oswald","year":"2007","journal-title":"PLoS Pathog"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.09.082_bib38","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.09.082_bib39","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.4049\/jimmunol.173.9.5372","article-title":"Vaccination in humans generates broad T cell cytokine responses","volume":"173","author":"De Rosa","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib40","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1128\/JVI.76.19.10038-10043.2002","article-title":"Sustained peptide-specific gamma interferon T-cell response in rhesus macaques immunized with human immunodeficiency virus gag DNA vaccines","volume":"76","author":"Caulfield","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.09.082_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clim.2003.11.015","article-title":"Flow cytometric analysis of vaccine responses: how many colors are enough?","volume":"110","author":"Roederer","year":"2004","journal-title":"Clin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08013431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T19:54:22Z","timestamp":1545681262000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08013431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":41,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0264410X08013431"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.09.082","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}